Compare OMH & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | IMCC |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 7.5M |
| IPO Year | 2023 | N/A |
| Metric | OMH | IMCC |
|---|---|---|
| Price | $1.53 | $1.34 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 131.9K |
| Earning Date | 11-28-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,264,748.00 | ★ $37,606,703.00 |
| Revenue This Year | $28.40 | $47.12 |
| Revenue Next Year | $23.07 | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 78.86 | 1.92 |
| 52 Week Low | $0.59 | $0.93 |
| 52 Week High | $4.46 | $7.12 |
| Indicator | OMH | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 84.02 | 43.70 |
| Support Level | $0.80 | $1.26 |
| Resistance Level | $1.83 | $1.45 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 72.64 | 39.39 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.